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Background: Periodontitis is the major cause of tooth loss in adults and is linked to systemic illnesses, such
ascardiovascular disease and stroke. The developmentof rapidpoint-of-care (POC) chairsidediagnosticshas
the potential for the early detection of periodontal infection and progression to identify incipient disease and
reduce health care costs. However, validation of effective diagnostics requires the identification and verifica-
tion of biomarkers correlated with disease progression. This clinical study sought to determine the ability of
putative host- and microbially derived biomarkers to identify periodontal disease status from whole saliva
and plaque biofilm.
Methods: One hundredhumansubjects were equally recruited into ahealthy/gingivitis group or aperiodontitis
population. Whole saliva was collected from all subjects and analyzed using antibody arrays to measure the levels
of multiple proinflammatory cytokines and bone resorptive/turnover markers.
Results: Salivary biomarker data were correlated to comprehensive clinical, radiographic, and microbial
plaque biofilm levels measured by quantitative polymerase chain reaction (qPCR) for the generation of models
for periodontal disease identification. Significantly elevated levels of matrix metalloproteinase (MMP)-8 and -9
were found in subjects with advanced periodontitis with Random Forest importance scores of 7.1 and 5.1, re-
spectively. The generation of receiver operating characteristic curves demonstrated that permutations of
salivary biomarkers and pathogen biofilm values augmented the prediction of disease category. Multiple com-
binationsof salivarybiomarkers (especiallyMMP-8and-9andosteoprotegerin)combinedwith red-complexan-
aerobic periodontal pathogens (such as Porphyromonas gingivalis or Treponema denticola) provided highly
accurate predictions of periodontal disease category. Elevated salivary MMP-8 and T. denticola biofilm levels
displayed robust combinatorial characteristics in predicting periodontal disease severity (area under the curve =
0.88; odds ratio = 24.6; 95% confidence interval: 5.2 to 116.5).
Conclusions: Using qPCR and sensitive immunoassays, we identified host- and bacterially derived bio-
markers correlated with periodontal disease. This approach offers significant potential for the discovery of
biomarker signatures useful in the development of rapid POC chairside diagnostics for oral and systemic
diseases. Studies are ongoing to apply this approach to the longitudinal predictions of disease activity.
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P
eriodontal disease is the leading cause of tooth
loss in adults.1 Periodontitis is initiated by tooth-
associated microbial biofilms triggering an al-
tered host response leading to soft tissue inflammation
and alveolar bone loss. Periodontal infections are
implicated in a variety of other diseases, such as car-
diovascular disease, stroke, and aspiration pneumonia,
whereby the microbial biofilm serves as a ‘‘slow-
delivery system’’ of oral pathogens adhering to teeth,
leading to a chronic microbial challenge and down-
stream effects of an altered host response.2 Diagnostic
methods used in clinical practice today lack the ability
to detect the onset of inflammation and to identify those
patients who are susceptible to future disease progres-
sion. Oral fluid–based point-of-care (POC) diagnostics
arecommonlyused in medicine and, more recently, are
being adapted for the potential ‘‘chairside’’ determina-
tion of oral diseases.3 The latest clinical applications
use new ‘‘lab-on-a-chip’’ (LOC) technologies as rapid
POC diagnostic tests for systemic infectious dis-
eases4,5 and periodontal disease.6 The human salivary
proteome project, supported by the United States
National Institute of Dental and Craniofacial Research,
Bethesda, Maryland, has generated further emphasis
on theuseofproteomicmarkers fordiseasediagnosis.7
The identification of the proteomic content of human
saliva in diagnostic tests, assessing the fingerprint of
different human illnesses, generally suggests the prob-
ability that multianalyte detection approaches will
surpass conventional clinical diagnostic procedures
using single biomarkers.
The use of oral fluids in oral-based diagnostics have
proven to be easy to use forPOC application8 in the de-
tection of oral cancer9,10 or human immunodeficiency
virus infection.11 Furthermore, the use of microfluidic
devices as examples of LOC technology offers signifi-
cant potential for rapid saliva diagnosis for widespread
public health purposes.6,12 However, for periodontal
disease determination, most research has focused pri-
marily on gingival crevicular fluid (GCF) biomarkers
that provide local disease status, but it represents a
cumbersome, difficult-to-use approach for clinical ap-
plication.13 Easy-to-access saliva contains locallyand
systemically derived mediators of periodontal disease
and, thus, offers significant potential for the assess-
ment of periodontal disease status and risk.14
Although a single specific target biomarker for peri-
odontal disease has not been identified, combinations
of putative biomarkers of disease have been evaluated
in GCF and demonstrated significant potential as
panels of targets for the development of an oral fluid
fingerprint of periodontal disease status. Given the
multifaceted pattern of periodontal disease as a con-
tinuum of infection to inflammatory dysregulation
and subsequent bone loss, specific biomarkers, such
as matrix metalloproteinase (MMP)-8, interleukin
(IL)-1b and -6, and type I collagen pyridinoline
cross-linked telopeptide (ICTP), have been assessed
in GCF singularly for disease identification.15 This ap-
proach of developing ‘‘biologic phenotypes’’ that con-
sider themicrobial and inflammatory responsemaybe
useful in the developmentofpatientdiseaseclassifica-
tions with implications in targeted therapeutics.16,17
Here we demonstrate the validation of multiple
proinflammatory and bone-specific biomarkers from
whole saliva coupled with microbial biofilm patho-
gens for the identification of periodontal disease. This
unique combinatorial approach resulted in robust pre-
dictions of periodontitis in human subjects.
MATERIALS AND METHODS
Subjects
This clinical study was approved by the University of
Michigan Health Sciences Institutional Review Board
and registered with the clinical trials database of the
National Institutes of Health, Bethesda, Maryland. Re-
search subjects were recruited from September 2005
through June 2006. Upon receiving written consent,
100 human subjects aged 18 years and older were
evaluated at the Michigan Center for Oral Health Re-
search. All subjects possessed ‡20 teeth and had re-
ceived no periodontal treatment or antibiotic therapy
for medical or dental reasons 3 months prior to the in-
vestigation. In addition, the subjects did not previ-
ously undergo any long-term use of medications
affecting periodontal status, such as anti-inflamma-
tory drugs.
Subjects were enrolled into a healthy/gingivitis po-
pulation (n = 50) or a periodontitis population (n = 49;
one patient dropped out at experimental baseline).
Subjects from the healthy and gingivitis population
exhibited <3 mm of attachment loss, no periodontal
probing depth (PD) >4 mm, and no radiographic alve-
olar bone loss. Periodontitis subjects exhibited at least
four sites with evidence of radiographic bone loss, at
least four sites with attachment loss >3 mm, and at
least four sites with PD >4 mm (Fig. 1).
Subjects were excluded if they possessed a history
of metabolic bone diseases, autoimmune diseases,
unstable diabetes, or postmenopausal osteoporosis.
Women who were pregnant were also excluded from
the study.
Clinical Measures
All teeth except third molars were assessed for peri-
odontal clinical measures by two calibrated examiners
(CR and JK). Clinical parameters, including PD, clin-
ical attachment level (CAL), and bleeding on probing
(BOP), were measured at six sites per tooth. Other
clinical assessments included dichotomous measures
of plaque accumulation (PI) and gingival redness in-
dex (GRI), as previously described by Haffajee et al.18
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Standardized periapical digital radiographs# were
taken in the posterior dentition of all subjects using
a parallel technique for the determination of alveolar
bone height. Using a computer software measurement
tool,** the interproximal alveolar bone levels of both
premolars and first and second molars were measured
on a digital computer screen by one calibrated exam-
iner (LR). The distance from the alveolar bone crest to
the cemento-enamel junction or the restorative margin
reference was recorded as the radiographic alveolar
bone level (RBL).
Quantitative Polymerase Chain Reaction (qPCR)
Microbial Plaque Biofilm Analysis
Plaque biofilm collection. Subgingival plaque biofilm
was collected from the mesio-buccal surfaces of all
teeth and immediately placed into labeled vials con-
taining 500 ml stabilizing buffer to prevent mRNA deg-
radation,†† as previously described.19 After vortexing
for 30 seconds, the samples were stored at 4C until
they were sent to the laboratory for analysis.
Detection of oral bacteria colonization in plaque
biofilm samples. The detection of Aggregatibacter
actinomycetemcomitans (previously Actinobacillus
actinomycetemcomitans), Campylobacter rectus,
Fusobacterium nucleatum, Prevotella intermedia,
Porphyromonas gingivalis, Tannerella forsythia (pre-
viously T. forsythensis), and Treponema denticola in
pooled plaque samples was evaluated by real-time
qPCR, as described,20,21 using primers specific for
the hypervariable segments
of the 16S rRNA genes of
each bacterium (Table 1).
The percentage of the total
flora for each species was
calculated by dividing the
number of target organisms
by the totalnumber of bacteria
as determined by qPCR using
16S rRNA primers that re-
actedwithall bacterial species.




was collected with passive
drooling into sterile plastic
tubes from all subjects at
the beginning of the screen-
ing appointment.22 The col-
lection was completed as
soon as 2 ml whole saliva
was collected or 15 minutes
of sampling time had elapsed.
Subsequently, the samples
were placed on ice, aliquotted,
and supplemented with a proteinase inhibitor com-
bination of 1% aprotinin and 0.5% phenylmethy-
lsulphonyl fluoride prior to storage at -80C.
Protein Biomarker Assays
Protein biomarker levels were determined using color-
imetric-based enzyme-linked immunosorbent assays
(ELISAs), fluorescence-based protein microarrays,
and radioimmunoassay (RIA), run according to
manufacturer protocols. ELISAs‡‡ were used for
measurement of MMP-8 and -9, calprotectin, and os-
teoprotegerin (OPG). Detection of the cytokines IL-
1b, -2, -4, -5, -6, -10, and -13, tumor necrosis
factor-alpha (TNF-a), and interferon (IFN)-g was
accomplished using a protein microarray.§§ The con-
centration of ICTP was determined using an RIA.ii
Prior to each assay, whole saliva samples were
thawed at room temperature and microcentrifuged
for 5 minutes to obtain cell-free supernatant for anal-
ysis. For ELISAs, absorbance measurements were
collected using a primary signal at 450 nm with back-
ground subtraction of the 540-nm signal. A fluo-
rescence scanner¶¶ was operated to collect Cy5
Figure 1.
Stratification of the low-risk population and the disease-susceptible population into four groups based on
clinical attachment loss, PD, RBL, and BOP.
# Schick Technologies, Long Island City, NY.
** Emago Advanced, Oral Diagnostic Systems, Amsterdam, The Nether-
lands.
†† RNA Protect, Ambion, Austin, TX.
‡‡ R&D Systems, Minneapolis, MN.
§§ Whatman, Florham Park, NJ.
ii Immunodiagnostic Systems, Fountain Hills, AZ.
¶¶ Molecular Devices, Sunnyvale, CA.
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fluorescence signal from the cytokine protein micro-
arrays. Data collection of the protein microarray sig-
nals was performed using software.##
Statistical Analysis
Basic demographics were summarized with means
and proportions for each subject group; between-
group comparisons were made with a one-way anal-
ysis of variance. Biomarker levels were summarized
with medians for each group; between-group com-
parisons were made with a Kruskal-Wallis test. Areas
under the curve (AUCs) for receiver operating charac-
teristic (ROC) curves were estimated non-parametri-
cally.23 Thresholds for biomarkers were preselected
as those values for which sensitivity and specificity
were as equal as possible. ROC curves and corre-
sponding AUCs for multiple biomarker combinations
were based upon predicted probabilities of diseased
subjects from a logistic regression model in which a
subject’s biomarker levels were dichotomized as be-
ing above or below their corresponding thresholds.
Furthermore, the biomarkers and microbial gene bio-
film levels were ranked in importance via Random
Forest methods.24 Statistical significance was defined
as P £0.05.
RESULTS
Fifty-seven female (74% white) and 42 male (81%
white) subjects, ranging in age from 20 to 77 years,
were enrolled in the study. Following the recording
of periodontal clinical and radiographic parameters,
the 99 subjects were stratified and subdivided into four
groups, according to previously described disease cat-
egories, prior to the analysis of the data (Fig. 1).25,26
From the healthy and gingivitis population, 18 sub-
jects were stratified as healthy (group A), with no
signs of periodontal breakdown and with BOP £20%.
Thirty-two subjects were categorized as having gingi-
vitis (BOP >20%) and no alveolar bone loss (group B).
From the periodontitis population, 28 subjects exhib-
iting £30% of sites with CAL >3 mm were classified as
having mild chronic periodontitis (group C), and 21
subjects were labeled as having moderate to severe
chronic periodontitis (group D); CAL >3 mm was
found in >30% of sites.
Dental and periodontal data (Table 2) were signif-
icantly different among the four groups for the mean
number of teeth (25 to 28; P <0.001), BOP (12% to
64%; P <0.001), GRI (13% to 56%; P <0.001), accumu-
lation of plaque (13% to 56%; P <0.001), mean PD
(1.49 to 3.03 mm; P <0.001), sites with PD >4 mm
(0% to 20%; P <0.001), mean CAL (0.59 to 2.93 mm;
P <0.001), and mean RBL (1.89 to 4.33 mm; P <
0.001). Additionally, the prevalence of smoking was
significantly higher in groups C and D (36% and
81%, respectively; P <0.001). The demographics for
gender and ethnicity were balanced among the four
groups. However, mean age was statistically signifi-
cantly different among the four groups (range, 42 to
53 years; P = 0.02).
Data from our analysis of putative biomarkers of
periodontal disease are shown in Table 3. Because
the majority (>70%) of the subjects did not have de-
tecable protein levels of IL-5 and IFN-g in their whole
saliva, these proteins were not included (data not
shown).
Compared to the healthier individuals, the median
levels of protein concentrations of MMP-8 (P <0.001),
MMP-9 (P = 0.001), and calprotectin (P = 0.023) were
increased in subjects with advancing stages of peri-
odontal disease. Increased levelsofOPG demonstrated
a significant ability to predict health (P = 0.007; Table
Table 1.
Primers for qPCR Analysis of Plaque Biofilm Bacteria
Bacterial Species Forward Primer (59–39) Reverse Primer (59–39)
A. actinomycetemcomitans GGCACGTAGGCGGACCTT ACCAGGGCTAAAGCCCAATC
C. rectus TTTCGGAGCGTAAACTCCTTTTC TTTCTGCAAGCAGACACTCTT
F. nucleatum ACCAGCGTTTGACATCTTAGGAATG AGCCATGCACCTGTCTTTAG
P. intermedia AGATTGACGGCCCTATGGGT CCGGTCCTTATTCGAAGGGTA
P. gingivalis CATAGATATCACGAGGAACTCCGATT AAACTGTTAGCAACTACCGATGTGG
T. forsythia GGGTGAGTAACGCGTATGTAACCT ACCCATCCGCAACCAATAAA
T. denticola CGTTCCTGGGCCTTGTACA TAGCGACTTCAGGTACCCTCG
Universal CCATGAAGTCGGAATCGCTAG GCTTGACGGGCGGTGT
## GenePix Pro, MDS Analytical Technologies, Toronto, ON.
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3). Various trends were noted for other biomarkers, in-
cluding ICTP and IL-1 and -6, but these were used to
rank significant. Random Forest methods were rank-
ing the importance of MMP-8 with a score of 7.1 and
OPG with a score of 6.3, reflecting the highest impor-
tance level among the biomarkers in this dataset.
Further analysis was done using a subset of bio-
markers demonstrating high Random Forest im-
portance scores, relatively low P values, and high
AUCs. The diagnostic properties of specific thresh-
olds that gave nearly equal levels of sensitivity and
specificity for our selection of biomarkers were se-
lected as cutoff values. MMP-8 and -9 and calprotectin
demonstrated significant abilities to predict disease
category (odds ratios [ORs] were 5.3 for MMP-8 and
-9 and 2.7 for calprotectin) (Table 4).
Table 3 shows the median levels as a percentage of
selected red and orange complex organisms for their
ability to identify periodontal disease category. A
greater diagnostic ability of these organisms was
demonstrated compared to the salivary biomarkers.
When comparing the healthy/gingivitis group to
the periodontitis group, T. denticola, P. gingivalis,
T. forsythia, P. intermedia, and C. rectus exhibited
significant differences (P <0.001); F. nucleatum and
Eikenella corrodens did not. When the diagnostic
properties were evaluated for the pathogens demon-
strating significant differences between the groups,
good sensitivity and specificity for disease category
were shown (Table 4). ORs (2.7 to 21.6) were also
found to be significant for T. denticola, P. gingivalis,
T. forsythia, P. intermedia, and C. rectus (Table 4).
Multianalyte assessments were performed using
variouscombinationsof salivarybiomarkersandplaque
biofilm levels (Fig. 2). For example, when MMP-8 and
calprotectin were combined to predict high-risk peri-
odontal status, an AUC of 0.74 was found with a cor-
responding OR = 3.9 (95% confidence interval [CI]:
1.3 to 11.6). When multiple biomarkers were com-
bined, such as MMP-8, OPG, and ICTP, the AUC in-
creased to 0.75 with OR = 10.1 (95% CI: 1.2 to
84.8; Fig. 2C). When the microbial biofilm was com-
bined with the biomarkers, the predictive values
increased markedly. Figure 2D depicts the
combination of MMP-8 and T. denticola with a resul-
tant AUC of 0.88 (OR = 24.6; 95% CI: 5.2 to 116.6).
Further improvements in the OR were noted when
several pathogens were combined. Given the rela-
tively small sample of 99 subjects, the OR could not
be determined for many combinations because in
all cases, periodontal disease category was correctly
identified when comprehensive combinations were
Table 2.

















C and DOverall Trend
Subjects (n) 18 32 28 21 NA NA NA
Males (%) 56 41 39 38 0.67 0.32 0.47
Whites (%) 78 78 68 86 0.54 0.80 0.78
Smokers (%) 0 19 36 81 <0.001 <0.001 <0.001
Mean number of teeth 28 27 26 25 <0.001 <0.001 <0.001
Mean age (years) 45 42 53 50 0.02 0.03 0.002
Sites with BOP (%) 12 31 52 64 <0.001 <0.001 <0.001
Sites with gingival redness (%) 13 22 49 56 <0.001 <0.001 <0.001
Sites with plaque (%) 24 26 57 61 <0.001 <0.001 <0.001
Mean PD (mm) 1.49 1.65 2.29 3.03 <0.001 <0.001 <0.001
Sites with PD >4 mm (%) 0 0 7 20 <0.001 <0.001 <0.001
Mean CAL (mm) 0.59 0.72 1.69 2.93 <0.001 <0.001 <0.001
Mean RBL (mm) 1.89 2.00 3.13 4.33 <0.001 <0.001 <0.001
NA = not applicable.
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chosen and were considered infinite for these permu-
tations (See supplementary table in online Journal of
Periodontology). These results suggest that although
the study of 99 subjects was able to determine differ-
ences in biomarker/biofilm levels to identify disease
category, a much larger sample is needed to generate
ORs that can be usable given the high level of accu-
racy demonstrated in this patient cohort.
DISCUSSION
To the best of our knowledge, this study demonstrates
for the first time the ability to use host-response sali-
vary biomarkers coupled with microbial biofilm DNA
to identify individuals with different stages of peri-
odontal disease. The results underscore the robustness
of combinatorial measures of disease mediators, such
as MMPs with putative periodontal pathogen genes, to
more accurately identify a patient’s status. These find-
ings may allow for rapid POC diagnostics to quickly
identify and screen at-risk patients in a more time-
effective manner compared to extensive clinical
examinations.
Our data identified key biomarkers from saliva and
biofilm that represent three distinct phases of peri-
odontitis: periodontal tissue inflammation (IL-1 and
-6), matrix degradation (MMP-8 and -9), and alveolar
bone turnover/resorption (osteoprotegerin and ICTP).
Complementing the dataset with anaerobic patho-
gens (particularly P. gingivalis, T. denticola, and T.
forsythia) augments the microbe–host influences on
periodontal disease identification to clinical measures
of disease status. These results represent an early ap-
proach to the identification of disease signatures for
periodontitis using rapid diagnostic techniques. Given
Table 3.






























MMP-8 (ng/ml) 23.6 (2.5 to 322.5) 54.1 (1 to 473.9) 129.9 (8.5 to 978.9) 203.8 (10.1 to 2,681.1) <0.001 <0.001 0.75 7.1
OPG (pg/ml) 2.3 (1.4 to 6.6) 2.7 (1.2 to 6.2) 1.9 (0.2 to 10.1) 1.6 (0.5 to 11.8) 0.056 0.007 0.62 6.3
MMP-9 (ng/ml) 106.4 (10 to 1,185.7) 225.8 (4.9 to 1,732.2) 301.6 (4.6 to 3,348.1) 780.8 (10.4 to 9,778.2) 0.002 0.001 0.72 5.1
Calprotectin
(ng/ml)
3.0 (1.3 to 10) 3.5 (0 to 24.6) 4.3 (0 to 17.8) 5.4 (1.7 to 97.6) 0.082 0.023 0.68 4.7
IL-1b (pg/ml) 158.6 (0 to 6,000) 206.7 (0 to 3,856.8) 247.5 (24.1 to 3,120) 462.2 (15.7 to 6,000) 0.157 0.059 0.72 3.7
ICTP (ng/ml) 0.9 (0 to 4) 0.8 (0 to 4) 0.6 (0 to 5.4) 0.9 (0 to 13.9) 0.195 0.185 0.58 3.2
IL-6 (pg/ml) 0.0 (0 to 1,915) 22.1 (0 to 8,784.9) 14.6 (0 to 5,259.7) 88.7 (0 to 10,816.9) 0.127 0.092 0.71 2.2
IL-10 (pg/ml) 881.4 (0 to 11,088.8) 120.6 (0 to 45,488.9) 1,153.1 (0 to 24,581.4) 1,445.1 (0 to 30,633.1) 0.618 0.329 0.68 1.9
TNF-a (pg/ml) 9.8 (0 to 1,788.3) 0.0 (0 to 3,720.5) 8.1 (0 to 4,370.2) 0.0 (0 to 8,212.7) 0.483 0.954 0.64 1.8
IL-13 (pg/ml) 14.3 (0 to 83,151.1) 0.0 (0 to 92,423.8) 0.0 (0 to 76,046) 169.9 (0 to 75,445.2) 0.780 0.783 0.64 1.5
IL-4 (pg/ml) 0.0 (0 to 5,315.1) 0.0 (0 to 6,579.3) 54.4 (0 to 14,588) 69.5 (0 to 11,714.3) 0.377 0.086 0.71 1.3
IL-2 (pg/ml) 0.0 (0 to 3,718.1) 0.0 (0 to 6,000) 8.0 (0 to 6,205.5) 0.0 (0 to 14,400.1) 0.421 0.178 0.69 1.2
T. denticola (%) 0.11 (0 to 0.54) 0.10 (0 to 2.95) 1.53 (0 to 5.25) 2.34 (0.79 to 6.63) <0.001 <0.001 0.86 13.7
P. gingivalis (%) 0.05 (0 to 0.9) 0.04 (0 to 0.66) 0.53(0 to 2.36) 1.00 (0.43 to 3.24) <0.001 <0.001 0.84 9.6
T. forsythia (%) 0.09 (0 to 0.88) 0.07 (0 to 0.8) 0.71 (0 to 3.16) 1.26 (0.11 to 3.55) <0.001 <0.001 0.85 8.4
P. intermedia (%) 0.11 (0 to 1.17) 0.20 (0 to 1.99) 0.82 (0 to 3.77) 1.85 (0 to 3.5) <0.001 <0.001 0.79 6.7
C. rectus (%) 0.00 (0 to 1.22) 0.00 (0 to 1.18) 0.66 (0 to 2.82) 1.32 (0 to 3.34) 0.001 <0.001 0.74 4.7
F. nucleatum (%) 2.96 (0 to 8.27) 2.33 (0 to 7.32) 3.29 (0 to 10.74) 3.30 (0 to 9.56) 0.251 0.196 0.59 3.9
E. corrodens (%) 0.00 (0 to 0.96) 0.00 (0 to 1.04) 0.00 (0 to 1.32) 0.00 (0 to 0.1) 0.697 0.259 0.56 0.3
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the multifactorial complexity of periodontitis as a poly-
genic disease, similar to cardiovascular disease and
osteoporosis, the consideration of multiple check-
points of disease (infection, inflammation, immune
dysregulation, and bone resorption) can now be
addressed with the use of multiple biomarkers that re-
flect the distinct stages of periodontitis. The periodon-
tology field has failed to come up with a ‘‘silver bullet’’
or specific biomarker for periodontal disease identifi-
cation. The results from this study suggest that patient
disease status might be able to be determined rapidly
using a combined proteomic/microbial genetic ap-
proach. The development of such methodologies
may have implications for rapid POC diagnostics for
oral and other systemic diseases; however, much
more information will be gleaned from longitudinal in-
vestigation.27
During the initiation of an inflammatory response in
the periodontal connective tissue, numerous cyto-
kines, such as IL-1b and -6 and TNF-a, are released
Table 4.
Diagnostic Properties of Specific Thresholds of Selected Salivary Biomarkers





Sensitivity Specificity OR 95% CINo (n) Yes (n)
MMP-8 (ng/ml) 87.0 - 28 12 0.69 0.70 5.3 2.0 to 13.7
+ 12 27
MMP-9 (ng/ml) 240.0 - 28 12 0.69 0.70 5.3 2.0 to 13.7
+ 12 27
Calprotectin (ng/ml) 3.6 - 25 15 0.62 0.63 2.7 1.1 to 6.6
+ 15 24
IL-6 (pg/ml) 22.4 - 24 16 0.59 0.60 2.2 0.9 to 5.3
+ 16 23
IL-1b (pg/ml) 235.8 - 22 18 0.54 0.55 1.4 0.6 to 3.5
+ 18 21
IL-10 (pg/ml) 520.9 - 22 18 0.54 0.55 1.4 0.6 to 3.5
+ 18 21
OPG (pg/ml) 2.0 - 17 22 0.44 0.43 0.6 0.2 to 1.4
+ 23 17
ICTP (ng/ml) 0.7 - 16 23 0.41 0.40 0.5 0.2 to 1.1
+ 24 16
T. denticola (%) 0.2 - 33 7 0.82 0.83 21.6 6.8 to 68.4
+ 7 32
T. forsythia (%) 0.1 - 32 8 0.80 0.80 15.5 5.2 to 46.4
+ 8 31
P. gingivalis (%) 0.1 - 31 8 0.80 0.78 13.3 4.6 to 39.1
+ 9 31
P. intermedia (%) 0.4 - 29 11 0.72 0.73 6.7 2.5 to 18
+ 11 28
C. rectus (%) 0.1 - 25 15 0.62 0.63 2.7 1.1 to 6.6
+ 15 24
F. nucleatum (%) 2.8 - 24 16 0.59 0.60 2.2 0.9 to 5.3
+ 16 23
E. corrodens (%) 0.0 - 35 31 0.21 0.88 1.8 0.5 to 6.1
+ 5 8
- = no; + = yes.
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from cells of the junctional epithelia, connective tissue
fibroblasts, and macrophages. Additionally, a number
of enzymes, such as MMP-8 and -9 and calprotectin,
are produced by PMNs and osteoclasts, leading to the
degradation of connective tissue collagen and alveo-
lar bone. During connective tissue inflammation and
following bone resorption, cytokines and bone resorp-
tive/turnover proteins migrate toward the gingival sul-
cus or periodontal pocket and further into GCF, where
they are released into and
contribute to whole saliva.
Host cell–derived MMP-8 and
-9 are believed to mediate,
to a substantial extent, the
matrix-destroying events dur-
ing the stages of periodontal
disease. The results from our
investigation are in agree-
ment with and extend the
overall findings that MMP-8
and -9 seem to be key bio-
markers that are elevated in
the oral fluids of periodontal
patients.28,29
These data support the
concept of the development
of periodontal signatures or
biologic phenotypes for dis-
ease classification that con-
sider the host phenotype
(response to the microbial
insult) and the nature of the
invading pathogens that initi-
ate periodontal disease.16
Specific biofilm organisms or
exposures may have the ca-
pacity to affect the ‘‘inflam-
matory set point’’ of the local
tissues in certain patients via
epigenetic mechanisms.30,31
Thus, the use of rapid chair-
side POC diagnostics that
identify disease in the context
of the host–microbe interac-
tion will likely lead to more
rationally tailored therapeu-
tic strategies. Offenbacher
et al.17 recently described
periodontaldiseaseat thebio-
film–gingival interface (BGI)
and noted from a molecular
epidemiologic investigation
that patients’ clinical pheno-
types are linked to biologic
phenotypes based on anti-
bodyresponse,microbialbio-
film levels, andGCF levels of specificproinflammatory
cytokines. The identification of these BGI classifica-
tions has led to distinct categories that contain ele-
vated antibody titers to P. gingivalis, C. rectus, and
T. denticola immunoglobulin G as well as increased
GCF concentrations of IL-1 and -6. Our data support
and expand these findings using salivary-derived bio-
markers for more rapid, easy-to-collect, and more
global whole-mouth assessment of inflammatory and
Figure 2.
A through F) ROC of combinatorial permutations of salivary biomarkers coupled with biofilm subgingival
pathogens measured by qPCR. Numbers in parentheses are 95% CIs.
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matrix-associated markers of periodontal disease. The




been well described,6,33-36 and the linkage between
red-complexbacteriaandcollagendestructionwasre-
ported.37,38 The red-complex bacteria are known for
their potent ability to display trypsin-like enzyme ac-
tivity that is responsible for destroying collagen matri-
ces.39 Thus, these data substantiate the combinatorial
use of MMP-destroying enzymes and corresponding
initiating pathogens, such as T. denticola, for peri-
odontal disease identification. The greatest usefulness
of these diagnostic approaches is the development of
predictive models for disease that need to be validated
in large, longitudinal studies. The patients involved in
this investigation were evaluated (Table 5) to deter-
mine the ability of these diagnostic approaches to pre-
dict progressive periodontal disease.40
Table 5.
Positive and Negative Predictive Values of Specific Thresholds of Selected Salivary





PPV NPVNo (n) Yes (n)
MMP-8 (ng/ml) 87.0 - 28 12 0.69 0.70
+ 12 27
MMP-9 (ng/ml) 240.0 - 28 12 0.69 0.70
+ 12 27
Calprotectin (ng/ml) 3.6 - 25 15 0.62 0.63
+ 15 24
IL-6 (pg/ml) 22.4 - 24 16 0.59 0.60
+ 16 23
IL-1b (pg/ml) 235.8 - 22 18 0.54 0.55
+ 18 21
IL-10 (pg/ml) 520.9 - 22 18 0.54 0.55
+ 18 21
OPG (pg/ml) 2.0 - 17 22 0.43 0.44
+ 23 17
ICTP (ng/ml) 0.7 - 16 23 0.40 0.41
+ 24 16
T. denticola (%) 0.2 - 33 7 0.82 0.83
+ 7 32
T. forsythia (%) 0.1 - 32 8 0.80 0.80
+ 8 31
P. gingivalis (%) 0.1 - 31 8 0.78 0.80
+ 9 31
P. intermedia (%) 0.4 - 29 11 0.72 0.73
+ 11 28
C. rectus (%) 0.1 - 25 15 0.62 0.63
+ 15 24
F. nucleatum (%) 2.8 - 24 16 0.59 0.60
+ 16 23
E. corrodens (%) 0.0 - 35 31 0.62 0.53
+ 5 8
PPV = positive predictive value; NPV = negative predictive value; - = no; + = yes.
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CONCLUSIONS
These data support the pairing of microbial and host-
response biomarker information for more accurate
periodontal diagnoses. Future clinical in-office appli-
cations of rapid POC diagnostics that can measure
proteins, genes, and biofilm pathogens in saliva
should lead to the development of improved disease
identification and improved oral health. These studies
require the longitudinal validation of these cross-sec-
tional approaches to determine the prediction of dis-
ease activity. The patients in this trial are being
monitored for the determination of disease progres-
sion to better forecast clinical disease outcomes.
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